Duloquin, Gauthier
Henon, Hilde
Pasi, Marco
Dequatre, Nelly
Della Schiava, Lucie
Kuchcinski, Gregory
Leclerc, Xavier
Cordonnier, Charlotte
Casolla, Barbara https://orcid.org/0000-0003-4199-995X
Article History
Received: 19 January 2022
Accepted: 27 January 2022
First Online: 8 February 2022
Declarations
:
: Verbal informed consent was obtained prior to the interview.
: None.
: BC: Amgen (speaker fees), CC: Boegringer-Ingelheim (speaker fees), BMS (steering committee), Biogen (steering committee), French ministry of health (grant A3ICH trial).Other authors: none.